Home LiteratureArticle Details
PMID: 7244362 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Antipyrine metabolites in two populations.

Research communications in chemical pathology and pharmacology ·Vol. 32 ·No. 2 ·1981-05-00 ·Pages 235-44

Inaba T, Uchino H, Kadar D, Kalow W

Abstract

After ingestion of 1 g antipyrine by healthy subjects of either Caucasian (n = 32) or Oriental (n = 18) background, urine was collected for 48 hr. and three major metabolites of antipyrine were determined. 21.8 +/- 1.1 (S.E.)% of the dose was excreted as 4-hydroxyantipyrine (4OHA), 12.7 +/- 0.6% as norantipyrine (NORA) and 5.9 +/- 0.3% as 3-hydroxy-methylantipyrine (3HMA). Oriental and Caucasian subjects showed similar mean recovery of each metabolite. The range of variation (F-test) of metabolite excretions between the 2 groups was again similar except for 3HMA which showed greater variation (p less than 0.01) in Orientals than in Caucasians. The fundamental similarity in antipyrine metabolism in the two populations is remarkable, because metabolite patterns of antipyrine differed significantly between subjects, and because the same two populations are known to differ much in their capacity for other drug oxidations.

MeSH Terms
Adult Antipyrine/metabolism Asians Female Humans Male Whites
Chemicals
Antipyrine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Inaba T
Uchino H
Kadar D
Kalow W
Article Info
Journal
Research communications in chemical pathology and pharmacology
Abbr.
Res Commun Chem Pathol Pharmacol
ISSN
0034-5164
Published
1981-05-00
Pages
235-44
Language
English
Region
United States
NLM ID
0244734
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com